Haihe Biopharma

About:

Haihe Biopharma is a biopharmaceutical company that develops cancer anti-tumour drugs.

Website: http://www.haihepharma.com/

Top Investors: Warburg Pincus, CICC, Legend Capital, Hillhouse Investment, CSPC Pharmaceutical Group

Description:

HaiHe Biopharma is a developer of innovative anti tumor drugs designed to overcome complex diseases and improve pharmacological evaluation. The company focuses on discovery, development and commercialization of innovative anti-tumor drugs, pharmacological efficacy evaluation and provide products including novel topoisomerase I inhibitors and oral c-Met highly selective inhibitors, enabling customers to improve their health conditions and research quality in an efficient manner.

Total Funding Amount:

$318M

Headquarters Location:

Shanghai, Shanghai, China

Founded Date:

2011-01-01

Contact Email:

bd(AT)haihepharma.com

Hub Tags:

Unicorn

Founders:

Jian Ding

Number of Employees:

251-500

Last Funding Date:

2020-07-24

IPO Status:

Private

© 2025 bioDAO.ai